Patents by Inventor Tillmann Rumenapf

Tillmann Rumenapf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isolation of a novel pestivirus causing congenital tremor A
    Patent number: 11529407
    Abstract: The present invention relates to a new pestivirus useful in the fields of veterinary virology and vaccines. Specifically, it relates to an isolated polynucleotide originating from pestivirus and a pestivirus, to vaccines and medical uses thereof, to chimeric virus comprising the polynucleotide and to expression vectors for heterologous expression of polypeptides.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: December 20, 2022
    Assignee: VETERINÄRMEDIZINISCHE UNIVERSITÄT WIEN
    Inventors: Hans Tillmann Rümenapf, Benjamin Lamp, Lukas Schwarz
  • ISOLATION OF A NOVEL PESTIVIRUS CAUSING CONGENITAL TREMOR A
    Publication number: 20210308248
    Abstract: The present invention relates to a new pestivirus useful in the fields of veterinary virology and vaccines. Specifically, it relates to an isolated polynucleotide originating from pestivirus and a pestivirus, to vaccines and medical uses thereof, to chimeric virus comprising the polynucleotide and to expression vectors for heterologous expression of polypeptides.
    Type: Application
    Filed: December 22, 2017
    Publication date: October 7, 2021
    Inventors: Hans Tillmann RÜMENAPF, Benjamin LAMP, Lukas SCHWARZ
  • Production of proteins by autoproteolytic cleavage
    Patent number: 7378512
    Abstract: The present invention relates to a process for the production of a heterologous polypeptide with homogeneous N-terminus in a bacterial host cell, wherein the heterologous polypeptide is autoproteolytically cleaved from an expressed fusion protein which comprises a polypeptide with the autoproteolytic activity of an autoprotease Npro of a pestivirus and the heterologous polypeptide by the Npro autoproteolytic activity.
    Type: Grant
    Filed: January 23, 2004
    Date of Patent: May 27, 2008
    Assignee: Biochemie Gesellschaft m.b.H
    Inventors: Tillmann Rumenapf, Heinz J Thiel, Jorg Windisch, Franz Knauseder
  • Production of proteins by autoproteolytic cleavage
    Publication number: 20040215008
    Abstract: The present invention relates to a process for the production of a heterologous polypeptide with homogeneous N-terminus in a bacterial host cell, wherein the heterologous polypeptide is autoproteolytically cleaved from an expressed fusion protein which comprises a polypeptide with the autoproteolytic activity of an autoprotease Npro of a pestivirus and the heterologous polypeptide by the Npro autoproteolytic activity.
    Type: Application
    Filed: January 23, 2004
    Publication date: October 28, 2004
    Inventors: Tillmann Rumenapf, Heinz Jurgen Thiel, Jorg Windisch, Franz Knauseder
  • Hog cholera virus vaccine and diagnostic
    Patent number: 5935582
    Abstract: The present invention is concerned with a hog cholera virus vaccine comprising a polypeptide characteristic of hog cholera virus. Vector vaccines capable to express a nucleic acid sequence encoding such a polypeptide also from part of the present invention. Said polypeptide and nucleic acid sequence can also be used for the detection of hog cholera virus infection.
    Type: Grant
    Filed: April 14, 1998
    Date of Patent: August 10, 1999
    Assignee: Akzo Nobel, N.V.
    Inventors: Gregor Meyers, Tillmann Rumenapf, Heinz-Jurgen Thiel
  • Hog cholera virus vaccine and diagnostic
    Patent number: 5925360
    Abstract: The present invention is concerned with a hog cholera virus vaccine comprising a polypeptide characteristic of hog cholera virus. Vector vaccines capable to express a nucleic acid sequence encoding such a polypeptide also form part of the present invention. Said polypeptide and nucleic acid sequence can also be used for the detection of hog cholera virus infection.
    Type: Grant
    Filed: June 16, 1997
    Date of Patent: July 20, 1999
    Assignee: Akzo Nobel N.V.
    Inventors: Gregor Meyers, Tillmann Rumenapf, Heinz-Jurgen Thiel
  • Hog cholera virus vaccine and diagnostic
    Patent number: 5811103
    Abstract: The present invention is concerned with a hog cholera virus vaccine comprising a polypeptide characteristic of hog cholera virus. Vector vaccines capable to express a nucleic acid sequence encoding such a polypeptide also form part of the present invention. Said polypeptide and nucleic acid sequence can also be used for the detection of hog cholera virus infection.
    Type: Grant
    Filed: June 12, 1997
    Date of Patent: September 22, 1998
    Assignee: Akzo Nobel N.V.
    Inventors: Gregor Meyers, Tillmann Rumenapf, Heinz-Jurgen Thiel